56 results on '"Tanaka, Shota"'
Search Results
2. SURG-43. SURGICAL TREATMENT FOR SPINAL CORD HEMANGIOBLASTOMA - DIFFERENCE IN SURGICAL INDICATION FROM CEREBRAL HEMANGIOBLASTOMA
3. NIMG-80. SKULL BASE CHORDOMA: CORRELATION OF18F-FDG PET/CT FINDINGS WITH PATHOLOGICAL FEATURES AND CLINICAL COURSE
4. CTNI-68. PHASE I/II STUDY OF MAINTENANCE THERAPY WITH METFORMIN AND TEMOZOLOMIDE FOR TARGETING GLIOBLASTOMA CANCER STEM CELLS
5. EPCO-32. DISSECTING THE INTRA- AND INTER-TUMORAL HETEROGENEITY UNDERLYING GLIOBLASTOMA PATHOGENESIS UTILIZING MULTI-OMICS ANALYSIS
6. EPCO-37. DISSECTING GBM EVOLUTION FOLLOWING STANDARD-OF-CARE BY LARGE-SCALE LONGITUDINAL SINGLE NUCLEUS RNA-SEQUENCING
7. EPCO-09. CHARACTERIZING THE GBM CELLULAR LANDSCAPE BY LARGE-SCALE SINGLE-NUCLEUS RNA-SEQUENCING
8. EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation
9. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts
10. SURG-10. DEVELOPMENT OF NOVEL TOPICAL FLUORESCENT PROBE FOR INTRAOPERATIVE RAPID DETECTION OF GLIOMA
11. FLGS-01. Development of novel topical fluorescent probe for intraoperative rapid detection of glioma
12. EPCO-01. MOLECULAR PROFILING OF SPINAL CORD EPENDYMOMA
13. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors
14. DIPG-17. BIOPSY-PROVEN DIFFUSE MIDLINE GLIOMA IN ADOLESCENTS AND YOUNG ADULTS
15. GCT-43. GAIN OF SHORT ARM OF CHROMOSOME 12 IS A MOLECULAR MARKER TO PREDICT PROGNOSIS AND REPRESENTS AN EARLY EVENT IN TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMORS
16. SURG-14. ENDOSCOPIC SURGERY FOR PEDIATRIC INTRAVENTRICULAR TUMOR WITHOUT HYDROCEPHALUS: INDICATION, SURGICAL TECHNIQUE, AVOIDANCE OF COMPLICATION, AND ITS PROSPECT
17. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
18. QOLP-07. HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH BEVACIZUMAB BEYOND PROGRESSION: A PROSPECTIVE TRIAL
19. SURG-32. DIFFERENCES IN SURGICAL OUTCOME BETWEEN VON HIPPEL-LINDAU DISEASE RELATED AND SPORADIC HEMANGIOBLASTOMAS IN THE CENTRAL NERVOUS SYSTEM
20. NIMG-29. DEVELOPING AUTOMATIC SEGMENTATION METHOD FOR BRAIN TUMOR MR IMAGES THAT CAN BE USED AT MULTIPLE FACILITIES
21. PATH-10. EFFECTS OF 19q-LOSS IN IDH-MUTATED ASTROCYTOMAS ON BETTER PROGNOSIS AND OLIGODENDROGLIOMA-LIKE MORPHOLOGY
22. PATH-33. EPIGENOMIC ANALYSIS OF SPINAL EPENDYMOMA
23. So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?
24. NIMG-11. VISUALIZATION OF JUDGMENT BASIS OF CNN TO GRADING GLIOMA
25. ATIM-07. EFFICACY AND SAFETY OF NIVOLUMAB IN PATIENTS WITH FIRST RECURRENCE OF GLIOBLASTOMA: A MULTICENTER, OPEN-LABEL, NON-COMPARATIVE STUDY (ONO-4538-19)
26. DDIS-02. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR GLIOBLASTOMA DETECTION
27. PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA
28. NIMG-49. THE ACCURACY EVALUATION OF ARCUATE FASCICULUS OF DIFFUSION TENSOR TRACTOGRAPHY BY FUSION OF REAL SPACE AND VIRTUAL SPACE
29. RARE-16. A NOVEL RADIOMICS MODEL DIFFERENTIATING CHORDOMA AND CHONDROSARCOMA
30. GENE-19. TARGETED SEQUENCING PANEL (TODAI ONCOPANEL) FOR VARIOUS TYPES OF BRAIN TUMORS
31. COMP-02. MINING-GUIDED MACHINE LEARNING ANALYSES SUPPORTS GRASPING THE LATEST TRENDS ON NEURO-ONCOLOGY
32. ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS
33. So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?
34. IMMU-58. REDUCED NEOANTIGEN EXPRESSION AS A POSSIBLE IMMUNE EVASION MECHANISM DURING GLIOMA PROGRESSION
35. NIMG-55. RADIOMICS ANALYSIS FOR DETECTION OF IDH MUTATION OF GLIOMA USING DIFFUSION TENSOR AND KURTOSIS IMAGES
36. SURG-11. PATHOLOGICAL INVESTIGATION OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS
37. NIMG-39. THE EVALUATION OF DIFFUSION TENSOR TRACTOGRAPHY USING MIXED REALITY INTEGRATED VIRTUAL SPACE AND REAL SPACE
38. TMIC-42. DEVELOPMENT OF NOVEL SPRAY-TYPE FLUORESCENT PROBES FOR BRAIN TUMORS
39. RARE-02. PRIMARY SPINAL CORD EWING’S SARCOMA IN 50-YEAR-OLD WOMAN: A CASE REPORT
40. GENE-10. CHARACTERISTIC MOLECULAR PROFILE CHANGES IN PRIMARY AND RECURRENT GLIOMAS DEPENDING ON THEIR HISTOPATHOLOGY
41. QLIF-46. THE EXPERIENCE OF MEDICAL CARE-RELATED DECISIONS AMONG MALIGNANT BRAIN TUMOR PATIENTS IN JAPAN: QUALITATIVE INTERVIEWS
42. GENE-60. INTEGRATED GENOMIC AND EPIGENOMIC ANALYSIS FOR HEMANGIOBLASTOMAS OF THE CENTRAL NERVOUS SYSTEM
43. PATH-21. IDH-MUTATED, 19q DELETED, TP53 MUTATED ANAPLASTIC GLIOMAS CONSTITUTE A SUBGROUP THAT LOOK LIKE AND BEHAVE LIKE ANAPLASTIC OLIGODENDROGLIOMAS
44. PATH-28. CLINICAL AND GENETIC CHARACTERISTICS OF DIFFUSE MIDLINE GLIOMA IN THE SPINAL CORD
45. Differences in genetic and epigenetic alterations between von Hippel–Lindau disease–related and sporadic hemangioblastomas of the central nervous system
46. GENT-23. MOLECULAR PATHOLOGICAL ANALYSIS ON IDH-WILDTYPE ADULT LOW-GRADE GLIOMAS
47. EXTH-37. CHEMOTHERAPY-INDUCED METABOLIC STRESS IN IDH1 MUTANT GLIOMAS
48. MPTH-13. GENETICALLY-GUIDED TREATMENTS OF GLIOBLASTOMA IN THE ELDERLY POPULATION
49. GENT-30. INTEGRATED GENOMIC ANALYSIS FOR VON HIPPEL-LINDAU DISEASE-RELATED AND SPORADIC HEMANGIOBLASTOMAS OF THE CENTRAL NERVOUS SYSTEM
50. CSIG-06. BRACHYURY AND ITS UPSTREAM, PI3K/AKT PATHWAY, ARE INVOLVED IN GROWTH OF SKULL BASE CHORDOMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.